+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Menopause Market Size, Share & Trends Analysis Report by Treatment (Dietary Supplements, OTC Pharma Products), by Region (North America, Europe, APAC, Latin America, MEA), and Segment Forecasts, 2021-2028

  • ID: 5415519
  • Report
  • June 2021
  • Region: Global
  • 100 Pages
  • Grand View Research

FEATURED COMPANIES

  • Abbott
  • Abbvie, Inc.
  • Bayer AG
  • Pure Encapsulations, LLC.
  • Theramex
The global menopause market size is expected to reach USD 22.7 billion by 2028. The market is expected to expand at a CAGR of 5.7% from 2021 to 2028. Increasing awareness regarding menopause-associated health aspects, high prevalence of menopausal symptoms, and high adoption of women’s health apps are expected to boost market growth during the forecast period. Key players in the region are conducting campaigns to create awareness about menopause and the role of dietary supplements in easing the transition through it. In September 2019, EQUELLE partnered with actress Kate Walsh for its campaign Live Hot, Stay Cool. The campaign included sharing of menopause-related experiences and tips by Kate with other women and the role that EQUELLE, a dietary supplement, played during the transition.





There are various dietary supplements available in the market containing ingredients such as soy isoflavones, black cohosh, red clover, and amberen. Manufacturers are involved in the launch of new products for managing menopause symptoms. For instance, in September 2020, Health and Her Ltd. launched a range of supplements for managing the symptoms of menopause, such as vitamins C and B12, zinc, minerals, and herbs. Such strategies can help meet the increasing demand for dietary supplements in the market.

Menopause Market Report Highlights

  • The dietary supplements segment dominated the market in terms of revenue share in 2020 and is expected to witness the fastest growth over the forecast period. The factors contributing to segment growth are a large number of women entering menopause every year and the launch of innovative products. Cambridge Diagnostic Imaging (CaDi), a provider of nutraceutical products for health support, announced the launch of Lycovary Daily in December 2020. The product is a food supplement developed by a biotech company, Lycotec, designed for ovarian health
  • The OTC pharma products segment is divided into hormonal and non-hormonal products. Over-the-Counter (OTC) hormone preparations are becoming more common for use by women undergoing menopause. Some of the major products in the segment include Dehydroepiandrosterone (DHEA), ibuprofen, topical progesterone, and melatonin
  • North America held the largest revenue share in the market in 2020 due to factors such as the growing prevalence of menopausal symptoms. Moreover, an increase in awareness about dietary requirements is leading to a greater demand for them among older women
  • In Latin America, the market is expected to register the fastest growth rate over the forecast period owing to factors such as rising awareness about women’s health and growing adoption of dietary supplements for menopause
  • The industry is also witnessing mergers, acquisitions, and product launches. For instance, in December 2017, Nestlé Health Science announced the acquisition of Atrium Innovations for USD 2.3 Million. This was anticipated to help Nestlé expand into the nutrition market


This product will be delivered within 1-3 business days.
Frequently Asked Questions about the Menopause Market

What is the estimated value of the Menopause Market?

The Menopause Market was estimated to be valued at $15.4 billion in 2021.

What is the growth rate of the Menopause Market?

The growth rate of the Menopause Market is 5.7%, with an estimated value of $22.7 billion by 2028.

What is the forecasted size of the Menopause Market?

The Menopause Market is estimated to be worth $22.7 billion by 2028.

Who are the key companies in the Menopause Market?

Key companies in the Menopause Market include Bayer AG, Theramex, Teva Pharmaceutical Industries Ltd., Abbvie, Inc., Abbott and Dr. Reddy’s Laboratories Ltd..
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott
  • Abbvie, Inc.
  • Bayer AG
  • Pure Encapsulations, LLC.
  • Theramex

Chapter 1 Methodology and Scope
1.1 Market Segmentation and Scope
1.1.1 Regional scope
1.1.2 Estimates and forecast timeline
1.2 Research Methodology
1.3 Information procurement
1.3.1 Purchased database:
1.3.2 Internal database
1.3.3 Secondary sources
1.3.4 Primary research
1.4 Information or Data Analysis
1.4.1 Data analysis models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.1.1 Approach 1: Commodity Flow Approach
1.7 Research Assumptions
1.8 List of Secondary Sources
1.9 List of Abbreviations
1.10 Objectives
1.10.1 Objective 1
1.10.2 Objective 2
1.10.3 Objective 3
1.10.4 Objective 4
Chapter 2 Executive Summary
2.1 Market Outlook
Chapter 3 Menopause Market Variables, Trends, and Scope
3.1 Market Lineage Outlook
3.1.1 Parent market outlook
3.1.2 Related/Ancillary Market Outlook
3.2 Penetration and Growth Prospect Mapping
3.3 Market Dynamics
3.3.1 Market Driver Analysis
3.3.1.1 Growing number of women undergoing menopause
3.3.1.2 Increasing awareness about menopause and its treatment
3.3.1.3 Growing opportunities and innovations in menopause treatment
3.3.1.4 Increasing research supporting advantages of dietary supplements
3.3.2 Market Restraint Analysis
3.3.2.1 Social stigma associated with menopause and adverse effects of products
3.3.2.2 Lack of well-defined regulations
3.4 Qualitative Analysis Impact of COVID-19 on Menopause Market
3.5 List of products
3.6 Market Dynamics
3.6.1 Industry Analysis: Porter’s
3.6.1.1 Threat of new entrants: Moderate
3.6.1.2 Bargaining power of buyers: Moderate
3.6.1.3 Threat of substitutes: High
3.6.1.4 Bargaining power of suppliers: Low
3.6.1.5 Competitive rivalry: High
3.6.2 PESTLE Analysis
3.6.3 Political and Legal
3.6.3.1 Strengths
3.6.3.2 Weaknesses
3.6.3.3 Opportunities
3.6.3.4 Threats
3.6.4 Economic
3.6.4.1 Strengths
3.6.4.2 Weaknesses
3.6.4.3 Opportunities
3.6.4.4 Threats
3.6.5 Social
3.6.5.1 Strengths
3.6.5.2 Weaknesses
3.6.5.3 Opportunities
3.6.5.4 Threats
3.6.6 Technological
3.6.6.1 Strengths
3.6.6.2 Weaknesses
3.6.6.3 Opportunities
3.6.6.4 Threats
Chapter 4 Menopause Market: Segment Analysis, by Treatment, 2016 - 2028 (USD Million)
4.1 Definition and Scope
4.2 Treatment Market Share Analysis, 2020 & 2028
4.3 Global Menopause Market, by Treatment, 2016 to 2028
4.4 Market Size & Forecasts and Trend Analyses, 2016 to 2028
4.4.1 Dietary Supplements
4.4.1.1 Dietary Supplements Market, 2016 - 2028 (USD Million)
4.4.2 OTC Pharma Products
4.4.2.1 OTC Pharma Products Market, 2016 - 2028 (USD Million)
4.4.2.2 Hormonal Products
4.4.2.2.1 Hormonal Products Market, 2016 - 2028 (USD Million)
4.4.2.3 Non-hormonal Products
4.4.2.3.1 Non-Hormonal Products Market, 2016 - 2028 (USD Million)
Chapter 5 Menopause Market: Regional Market Analysis, 2016 - 2028 (USD Million)
5.1 Definition & Scope
5.2 Regional Market Share Analysis, 2020 & 2028
5.3 Regional Market Dashboard
5.4 Regional Market Snapshot
5.5 Market Size, & Forecasts, Trend Analysis, 2020 to 2028
5.6 North America
5.6.1 North America Dietary Supplements Market
5.6.2 North America Dietary Supplements market estimates and forecast, 2016 - 2028 (USD Million)
5.6.3 North America OTC Pharma Products Market
5.6.4 North America OTC Pharma products market estimates and forecast, 2016 - 2028 (USD Million)
5.6.5 U.S.
5.6.5.1 U.S. Dietary Supplements Market
5.6.5.2 U.S. Dietary Supplements Market, 2016 - 2028 (USD Million)
5.6.5.3 U.S. OTC Pharma Products Market
5.6.5.4 U.S. OTC Pharma Products Market, 2016 - 2028 (USD Million)
5.6.6 Canada
5.6.6.1 Canada Dietary Supplements Market
5.6.6.2 Canada Dietary Supplements Market, 2016 - 2028 (USD Million)
5.6.6.3 Canada OTC Pharma Products Market
5.6.6.4 Canada OTC Pharma Products Market, 2016 - 2028 (USD Million)
5.7 Europe
5.7.1 Europe Dietary Supplements Market
5.7.2 Europe Dietary Supplements Market, 2016 - 2028 (USD Million)
5.7.3 Europe OTC Pharma Products Market
5.7.4 Europe OTC Pharma Products Market, 2016 - 2028 (USD Million)
5.7.5 U.K.
5.7.5.1 U.K. Dietary Supplements Market
5.7.5.2 U.K. Dietary Supplements Market, 2016 - 2028 (USD Million)
5.7.5.3 U.K. OTC Pharma Products Market
5.7.5.4 U.K. OTC Pharma Products Market, 2016 - 2028 (USD Million)
5.7.6 Germany
5.7.6.1 Germany Dietary Supplements Market
5.7.6.2 Germany Dietary Supplements Market, 2016 - 2028 (USD Million)
5.7.6.3 Germany OTC Pharma Products Market
5.7.6.4 Germany OTC Pharma Products Market, 2016 - 2028 (USD Million)
5.7.7 Spain
5.7.7.1 Spain Dietary Supplements Market
5.7.7.2 Spain Dietary Supplements Market, 2016 - 2028 (USD Million)
5.7.7.3 Spain OTC Pharma Products Market
5.7.7.4 Spain OTC Pharma Products Market, 2016 - 2028 (USD Million)
5.7.8 France
5.7.8.1 France Dietary Supplements Market
5.7.8.2 France Dietary Supplements market, 2016 - 2028 (USD Million)
5.7.8.3 France OTC Pharma Products Market
5.7.8.4 France OTC Pharma Products Market, 2016 - 2028 (USD Million)
5.7.9 Italy
5.7.9.1 Italy Dietary Supplements Market
5.7.9.2 Italy Dietary Supplements Market, 2016 - 2028 (USD Million)
5.7.9.3 Italy OTC Pharma Products Market
5.7.9.4 Italy OTC Pharma Products Market, 2016 - 2028 (USD Million)
5.7.10 Austria
5.7.10.1 Austria Dietary Supplements Market
5.7.10.2 Austria Dietary Supplements Market, 2016 - 2028 (USD Million)
5.7.10.3 Austria OTC Pharma Products Market
5.7.10.4 Austria OTC Pharma Products Market, 2016 - 2028 (USD Million)
5.8 Asia Pacific
5.8.1 Asia Pacific Dietary Supplements Market
5.8.2 Asia Pacific Dietary Supplements market estimates and forecast, 2016 - 2028 (USD Million)
5.8.3 Asia Pacific OTC Pharma Products Market
5.8.4 Asia Pacific OTC Pharma products market estimates and forecast, 2016 - 2028 (USD Million)
5.8.5 Japan
5.8.5.1 Japan Dietary Supplements Market
5.8.5.2 Japan Dietary Supplements Market, 2016 - 2028 (USD Million)
5.8.5.3 Japan OTC Pharma Products Market
5.8.5.4 Japan OTC Pharma Products Market, 2016 - 2028 (USD Million)
5.8.6 China
5.8.6.1 China Dietary Supplements Market
5.8.6.2 China Dietary Supplements Market, 2016 - 2028 (USD Million)
5.8.6.3 China OTC Pharma Products Market
5.8.6.4 China OTC Pharma Products Market, 2016 - 2028 (USD Million)
5.8.7 India
5.8.7.1 India Dietary Supplements Market
5.8.7.2 India Dietary Supplements Market, 2016 - 2028 (USD Million)
5.8.7.3 India OTC Pharma Products Market
5.8.7.4 India OTC Pharma Products Market, 2016 - 2028 (USD Million)
5.8.8 South Korea
5.8.8.1 South Korea Dietary Supplements Market
5.8.8.2 South Korea Dietary Supplements Market, 2016 - 2028 (USD Million)
5.8.8.3 South Korea OTC Pharma Products Market
5.8.8.4 South Korea OTC Pharma Products Market, 2016 - 2028 (USD Million)
5.9 Latin America
5.9.1 Latin America Dietary Supplements Market
5.9.2 Latin America Dietary Supplements Market, 2016 - 2028 (USD Million)
5.9.3 Latin America OTC Pharma Products Market
5.9.4 Latin America OTC Pharma Products Market, 2016 - 2028 (USD Million)
5.9.5 Brazil
5.9.5.1 Brazil Dietary Supplements Market
5.9.5.2 Brazil Dietary Supplements Market, 2016 - 2028 (USD Million)
5.9.5.3 Brazil OTC Pharma Products Market
5.9.5.4 Brazil OTC Pharma Products Market, 2016 - 2028 (USD Million)
5.9.6 Mexico
5.9.6.1 Mexico Dietary Supplements Market
5.9.6.2 Mexico Dietary Supplements Market, 2016 - 2028 (USD Million)
5.9.6.3 Mexico OTC Pharma Products Market
5.9.6.4 Mexico OTC Pharma Products Market, 2016 - 2028 (USD Million)
5.10 MEA
5.10.1 MEA Dietary Supplements Market
5.10.2 MEA Dietary Supplements Market, 2016 - 2028 (USD Million)
5.10.3 MEA OTC Pharma Products Market
5.10.4 MEA OTC Pharma Products Market, 2016 - 2028 (USD Million)
5.10.5 South Africa
5.10.5.1 South Africa Dietary Supplements Market
5.10.5.2 South Africa Dietary Supplements Market, 2016 - 2028 (USD Million)
5.10.5.3 South Africa OTC Pharma Products Market
5.10.5.4 South Africa OTC Pharma Products Market, 2016 - 2028 (USD Million)
Chapter 6 Menopause Market: Competitive Landscape
6.1 Recent developments & impact analysis, by key market participants
6.1.1 Ansoff matrix
6.2 Company Categorization
6.2.1 Innovators
6.2.2 Market Leaders
6.3 Vendor Landscape
6.3.1 List of key distributors and channel partners
6.3.2 Key customers
6.4 Public Companies
6.4.1 Company Market position analysis
6.4.2 Competitive Dashboard Analysis
6.4.2.1 Market Differentiators
6.5 Company Profiles
6.5.1 Bayer AG
6.5.1.1 Company overview
6.5.1.2 Financial performance
6.5.1.3 Product benchmarking
6.5.2 Theramex
6.5.2.1 Company overview
6.5.2.2 Product benchmarking
6.5.2.3 Strategic initiatives
6.5.3 Teva Pharmaceutical Industries Ltd.
6.5.3.1 Company overview
6.5.3.2 Financial performance
6.5.3.3 Product benchmarking
6.5.3.4 Strategic initiatives
6.5.4 Abbvie, Inc.
6.5.4.1 Company overview
6.5.4.2 Financial performance
6.5.4.3 Product benchmarking
6.5.4.4 Strategic initiatives
6.5.5 Abbott
6.5.5.1 Company overview
6.5.5.2 Financial performance
6.5.5.3 Product benchmarking
6.5.6 Pure Encapsulations, LLC.
6.5.6.1 Company overview
6.5.6.2 Financial performance
6.5.6.3 Product benchmarking
6.5.6.4 Strategic initiatives
6.5.7 Dr. Reddy’s Laboratories Ltd.
6.5.7.1 Company overview
6.5.7.2 Financial performance
6.5.7.3 Product benchmarking
6.5.7.4 Strategic initiatives
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviation
Table 3 Global dietary supplements market estimates and forecast, 2016 - 2028 (USD Million)
Table 4 Global OTC pharma products market estimates and forecast, 2016 - 2028 (USD Million)
Table 5 North America menopause market estimates and forecast, 2016 - 2028 (USD Million)
Table 6 North America menopause market revenue estimates and forecast by treatment, 2016 - 2028 (USD Million)
Table 7 U.S. menopause market estimates and forecast, 2016 - 2028 (USD Million)
Table 8 U.S. menopause market revenue estimates and forecast by treatment, 2016 - 2028 (USD Million)
Table 9 Canada menopause market estimates and forecast, 2016 - 2028 (USD Million)
Table 10 Canada menopause market revenue estimates and forecast by treatment, 2016 - 2028 (USD Million)
Table 11 Europe menopause market estimates and forecast, 2016 - 2028 (USD Million)
Table 12 Europe menopause market revenue estimates and forecast by treatment, 2016 - 2028 (USD Million)
Table 13 U.K. menopause market estimates and forecast, 2016 - 2028 (USD Million)
Table 14 U.K. menopause market revenue estimates and forecast by treatment, 2016 - 2028 (USD Million)
Table 15 Germany menopause market estimates and forecast, 2016 - 2028 (USD Million)
Table 16 Germany menopause market revenue estimates and forecast by treatment, 2016 - 2028 (USD Million)
Table 17 France menopause market estimates and forecast, 2016 - 2028 (USD Million)
Table 18 France menopause market revenue estimates and forecast by treatment, 2016 - 2028 (USD Million)
Table 19 Italy menopause market estimates and forecast, 2016 - 2028 (USD Million)
Table 20 Italy menopause market revenue estimates and forecast by treatment, 2016 - 2028 (USD Million)
Table 21 Spain menopause market estimates and forecast, 2016 - 2028 (USD Million)
Table 22 Spain menopause market revenue estimates and forecast by treatment, 2016 - 2028 (USD Million)
Table 23 Austria menopause market estimates and forecast, 2016 - 2028 (USD Million)
Table 24 Austria menopause market revenue estimates and forecast by treatment, 2016 - 2028 (USD Million)
Table 25 Asia Pacific menopause market estimates and forecast, 2016 - 2028 (USD Million)
Table 26 Asia Pacific menopause market revenue estimates and forecast by treatment, 2016 - 2028 (USD Million)
Table 27 China menopause market estimates and forecast, 2016 - 2028 (USD Million)
Table 28 China menopause market revenue estimates and forecast by treatment, 2016 - 2028 (USD Million)
Table 29 Japan menopause market estimates and forecast, 2016 - 2028 (USD Million)
Table 30 Japan menopause market revenue estimates and forecast by treatment, 2016 - 2028 (USD Million)
Table 31 India menopause market estimates and forecast, 2016 - 2028 (USD Million)
Table 32 India menopause market revenue estimates and forecast by treatment, 2016 - 2028 (USD Million)
Table 33 South Korea menopause market estimates and forecast, 2016 - 2028 (USD Million)
Table 34 South Korea menopause market revenue estimates and forecast by treatment, 2016 - 2028 (USD Million)
Table 35 Latin America menopause market estimates and forecast, 2016 - 2028 (USD Million)
Table 36 Latin America menopause market revenue estimates and forecast by treatment, 2016 - 2028 (USD Million)
Table 37 Brazil menopause market estimates and forecast, 2016 - 2028 (USD Million)
Table 38 Brazil menopause market revenue estimates and forecast by treatment, 2016 - 2028 (USD Million)
Table 39 Mexico menopause market estimates and forecast, 2016 - 2028 (USD Million)
Table 40 Mexico menopause market revenue estimates and forecast by treatment, 2016 - 2028 (USD Million)
Table 41 Middle East & Africa (MEA) menopause market estimates and forecast, 2016 - 2028 (USD Million)
Table 42 Middle East & Africa (MEA) menopause market revenue estimates and forecast by treatment, 2016 - 2028 (USD Million)
Table 43 South Africa menopause market estimates and forecast, 2016 - 2028 (USD Million)
Table 44 South Africa menopause market revenue estimates and forecast by treatment, 2016 - 2028 (USD Million)
List of Figures
Fig. 1 Menopause market segmentation
FIG. 2 Market research process
FIG. 3 Information procurement
FIG. 4 Primary research pattern
FIG. 5 Market research approaches
FIG. 6 Value-chain-based sizing & forecasting
FIG. 7 QFD modeling for market share assessment
FIG. 8 Market formulation & validation
FIG. 9 Menopause market outlook (2020)
FIG. 10 Penetration & growth prospect mapping
FIG. 11 Market driver relevance analysis (Current & future impact)
FIG. 12 Market restraint relevance analysis (Current & future impact)
FIG. 13 Menopause market: Treatment movement analysis
FIG. 14 Menopause market treatment outlook: Key takeaways
FIG. 15 Dietary supplements market, 2016 - 2028 (USD Million)
FIG. 16 OTC pharma products market, 2016 - 2028 (USD Million)
FIG. 17 Hormonal products market, 2016 - 2028 (USD Million)
FIG. 18 Non-hormonal products market, 2016 - 2028 (USD Million)
FIG. 19 Regional outlook, 2020 & 2028
FIG. 20 Regional market dashboard
FIG. 21 Regional marketplace: Key takeaways
FIG. 22 North America dietary supplements market
FIG. 23 North America dietary supplements market estimates and forecast, 2016 - 2028 USD (Million)
FIG. 24 North America OTC pharma products market
FIG. 25 North America OTC pharma products market estimates and forecast, 2016 - 2028 USD (Million)
FIG. 26 U.S. dietary supplements market
FIG. 27 U.S. dietary supplements market estimates and forecast, 2016 - 2028 USD (Million)
FIG. 28 U.S. OTC pharma products market
FIG. 29 U.S. OTC pharma products market estimates and forecast, 2016 - 2028 USD (Million)
FIG. 30 Canada dietary supplements market
FIG. 31 Canada dietary supplements market estimates and forecast, 2016 - 2028 USD (Million)
FIG. 32 Canada OTC pharma products market
FIG. 33 Canada OTC pharma products market estimates and forecast, 2016 - 2028 USD (Million)
FIG. 34 Europe dietary supplements market
FIG. 35 Europe dietary supplements market estimates and forecast, 2016 - 2028 USD (Million)
FIG. 36 Europe OTC pharma products market
FIG. 37 Europe OTC pharma products market estimates and forecast, 2016 - 2028 USD (Million)
FIG. 38 U.K. dietary supplements market
FIG. 39 U.K. dietary supplements market estimates and forecast, 2016 - 2028 USD (Million)
FIG. 40 U.K. OTC pharma products market
FIG. 41 U.K. OTC pharma products market estimates and forecast, 2016 - 2028 USD (Million)
FIG. 42 Germany dietary supplements market
FIG. 43 Germany dietary supplements market estimates and forecast, 2016 - 2028 USD (Million)
FIG. 44 Germany OTC pharma products market
FIG. 45 Germany OTC pharma products market estimates and forecast, 2016 - 2028 USD (Million)
FIG. 46 Spain dietary supplements market
FIG. 47 Spain dietary supplements market estimates and forecast, 2016 - 2028 USD (Million)
FIG. 48 Spain OTC pharma products market
FIG. 49 Spain OTC pharma products market estimates and forecast, 2016 - 2028 USD (Million)
FIG. 50 France dietary supplements market
FIG. 51 France dietary supplements market estimates and forecast, 2016 - 2028 USD (Million)
FIG. 52 France OTC pharma products market
FIG. 53 France OTC pharma products market estimates and forecast, 2016 - 2028 USD (Million)
FIG. 54 Italy dietary supplements market
FIG. 55 Italy dietary supplements market estimates and forecast, 2016 - 2028 USD (Million)
FIG. 56 Italy OTC pharma products market
FIG. 57 Italy OTC pharma products market estimates and forecast, 2016 - 2028 USD (Million)
FIG. 58 Austria dietary supplements market
FIG. 59 Austria dietary supplements market estimates and forecast, 2016 - 2028 USD (Million)
FIG. 60 Austria OTC pharma products market
FIG. 61 Austria OTC pharma products market estimates and forecast, 2016 - 2028 USD (Million)
FIG. 62 Asia Pacific dietary supplements market
FIG. 63 Asia Pacific dietary supplements market estimates and forecast, 2016 - 2028 USD (Million)
FIG. 64 Asia Pacific OTC pharma products market
FIG. 65 Asia Pacific OTC pharma products market estimates and forecast, 2016 - 2028 USD (Million)
FIG. 66 Japan dietary supplements market
FIG. 67 Japan dietary supplements market estimates and forecast, 2016 - 2028 USD (Million)
FIG. 68 Japan OTC pharma products market
FIG. 69 Japan OTC pharma products market estimates and forecast, 2016 - 2028 USD (Million)
FIG. 70 China dietary supplements market
FIG. 71 China dietary supplements market estimates and forecast, 2016 - 2028 USD (Million)
FIG. 72 China OTC pharma products market
FIG. 73 China OTC pharma products market estimates and forecast, 2016 - 2028 USD (Million)
FIG. 74 India dietary supplements market
FIG. 75 India dietary supplements market estimates and forecast, 2016 - 2028 USD (Million)
FIG. 76 India OTC pharma products market
FIG. 77 India OTC pharma products market estimates and forecast, 2016 - 2028 USD (Million)
FIG. 78 South Korea dietary supplements market
FIG. 79 South Korea dietary supplements market estimates and forecast, 2016 - 2028 USD (Million)
FIG. 80 South Korea OTC pharma products market
FIG. 81 South Korea OTC pharma products market estimates and forecast, 2016 - 2028 USD (Million)
FIG. 82 Latin America dietary supplements market
FIG. 83 Latin dietary supplements market estimates and forecast, 2016 - 2028 USD (Million)
FIG. 84 Latin America OTC pharma products market
FIG. 85 Latin America OTC pharma products market estimates and forecast, 2016 - 2028 USD (Million)
FIG. 86 Brazil dietary supplements market
FIG. 87 Brazil dietary supplements market estimates and forecast, 2016 - 2028 USD (Million)
FIG. 88 Brazil OTC pharma products market
FIG. 89 Brazil OTC pharma products market estimates and forecast, 2016 - 2028 USD (Million)
FIG. 90 Mexico dietary supplements market
FIG. 91 Mexico dietary supplements market estimates and forecast, 2016 - 2028 USD (Million)
FIG. 92 Mexico OTC pharma products market
FIG. 93 Mexico OTC pharma products market estimates and forecast, 2016 - 2028 USD (Million)
FIG. 94 MEA dietary supplements market
FIG. 95 MEA dietary supplements market estimates and forecast, 2016 - 2028 USD (Million)
FIG. 96 MEA OTC pharma products market
FIG. 97 MEA OTC pharma products market estimates and forecast, 2016 - 2028 USD (Million)
FIG. 98 South Africa dietary supplements market
FIG. 99 South Africa dietary supplements market estimates and forecast, 2016 - 2028 USD (Million)
FIG. 100 South Africa OTC pharma products market
FIG. 101 South Africa OTC pharma products market estimates and forecast, 2016 - 2028 USD (Million)
Note: Product cover images may vary from those shown
  • Bayer AG
  • Theramex
  • Teva Pharmaceutical Industries Ltd.
  • Abbvie, Inc.
  • Abbott
  • Pure Encapsulations, LLC.
  • Dr. Reddy’s Laboratories Ltd.
Note: Product cover images may vary from those shown

Loading
LOADING...